Market By Technology, Disease, Type And Geography | Forecast 2019-2027
According to Triton, the global genetic testing market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 11.53%. The market was assessed to be worth $8407.48 million in the year 2018 and is predicted to generate a revenue of approximately $22438.48 million by the year 2027.
The high growth rate for this market is primarily attributed to increasing emphasis on early disease detection and prevention, increasing demand for personalized medicine, along with increasing applications of genetic testing in cancerous diseases. Moreover, the increasing ratio of health-conscious population in the developed regions is acting as a major growth driver for this market. Personalized medicine yields a spectrum of product opportunities for the pharmaceutical industries and contributes to their commercial success. As a result, the growing demand for personalized medicine is expected to drive the growth of the market studied.
Report scope can be customized per your requirements. Request For Customization
Genetic testing types are expected to witness lucrative growth. Carrier testing is a type of genetic testing used to determine whether a person is a carrier for specific autosomal recessive diseases. Diagnostic testing is used to identify a genetic condition or a disease and the results of these tests help in treating and managing the disorder. Market definition regarding the industry has been discussed within this report. Also, the key insights, market attractiveness index, Porter’s five force analysis have been studied for the global genetic testing Industry.
Market drivers comprise of increasing early diagnosis of diseases, rising demand for personalized medicine and increase in awareness about cancer and genetic testing in oncology. The industry is facing market restraints like high price of genetic testing and social and ethical issues associated with genetic testing.
Key opportunities like increasing number of patients seeking genetic counseling and testing and increase in infertility rate create an opportunity for genetic testing market. Genetic counselor diagnoses and care for people with genetic conditions. They provide information and support to people with genetic conditions and their families.
A challenge such as stringent regulation is a major barrier for genetic testing. The continuous tussle between market players and regulatory authorities, with respect to evolving technology, presents a challenging environment for the new and established players in the market.
Report scope can be customized per your requirements. Request For Customization
Geographies covered for the global genetic testing market:
O North America: The United States and Canada
O Europe: The United Kingdom, Germany, France, Spain, Italy, Russia and rest of Europe
O Asia-Pacific: China, Japan, India, South Korea, Australia & New Zealand, ASEAN countries, and rest of Asia Pacific
O The Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and rest of the Middle East and Africa
O Latin America: Mexico, Brazil, and rest of Latin America
The report on global genetic testing market includes segmentation on the basis of type, disease and technology.
O Type is segmented into:
• Carrier Testing
• Diagnostic Testing
• Newborn Screening
• Predictive and Pre-symptomatic Testing
• Prenatal Testing
• Pharmacogenomics
• Other Types
O Disease is segmented into:
• Alzheimer’s Disease
• Cancer
• Cystic Fibrosis
• Sickle Cell Anemia
• Duchenne Muscular Dystrophy
• Thalassemia
• Huntington’s Disease
• Special Diseases
• Other Diseases
O Technology is segmented into:
• Cytogenetic Testing
• Biochemical Testing
• Molecular Testing
The companies engaged in the global genetic testing market are Abbott Laboratories, Inc., Bio-Rad Laboratories, Danaher Corporation (Cepheid), Daan Diagnostics, Ltd., F. Hoffmann-La Roche, Ltd., Genentech, Inc., Genomictree, Inc., HTG Molecular Diagnostics, Inc., Illumina, Inc., Integragen S.A., Laboratory Corporation of America Holdings, Luminex Corporation, Molecular MD Corp. (Acquired By Icon), Myriad Genetics, Inc., Natera, Inc., Oxford Biodynamics, Limited, Pacific Biosciences of California, Inc., Perkinelmer, Inc., Qiagen N.V., Roche Diagnostics Corporation and Thermo Fisher Scientific, Inc.
The strategic analysis for each of these companies in the global genetic testing market has been covered in detail.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GENETIC
TESTING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. PESTEL
OUTLOOK
2.4. KEY
INSIGHTS
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. MARKET
DRIVERS
2.6.1. RISING
TREND OF EARLY DIAGNOSIS OF DISEASES
2.6.2. RISING
DEMAND FOR PERSONALIZED MEDICINE
2.6.3. GROWING
AWARENESS ABOUT CANCER AND GENETIC TESTING IN ONCOLOGY
2.7. MARKET
RESTRAINTS
2.7.1. HIGH
PRICE OF GENETIC TESTING
2.7.2. SOCIAL
AND ETHICAL ISSUES ASSOCIATED WITH GENETIC TESTING
2.8. MARKET
OPPORTUNITIES
2.8.1. INCREASING
NUMBER OF PATIENTS SEEKING GENETIC COUNSELING AND TESTING
2.8.2. SURGE
IN INFERTILITY RATE
2.9. MARKET
CHALLENGES
2.9.1. STRINGENT
REGULATION
3. GENETIC
TESTINGS MARKET OUTLOOK - BY TECHNOLOGY
3.1. CYTOGENETIC
TESTING
3.2. BIOCHEMICAL
TESTING
3.3. MOLECULAR
TESTING
4. GENETIC
TESTINGS MARKET OUTLOOK - BY DISEASE
4.1. ALZHEIMER’S
DISEASE
4.2. CANCER
4.3. CYSTIC
FIBROSIS
4.4. SICKLE
CELL ANEMIA
4.5. DUCHENNE
MUSCULAR DYSTROPHY
4.6. THALASSEMIA
4.7. HUNTINGTON’S
DISEASE
4.8. SPECIAL
DISEASES
4.9. OTHER
DISEASES
5. GENETIC
TESTINGS MARKET OUTLOOK - BY TYPE
5.1. CARRIER
TESTING
5.2. DIAGNOSTIC
TESTING
5.3. NEWBORN
SCREENING
5.4. PREDICTIVE
AND PRESYMPTOMATIC TESTING
5.5. PRENATAL
TESTING
5.6. PHARMACOGENOMICS
5.7. OTHER
TYPES
6. GENETIC
TESTING MARKET - REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. COUNTRY
ANALYSIS
6.1.1.1. THE
UNITED STATES
6.1.1.2. CANADA
6.2. EUROPE
6.2.1. COUNTRY
ANALYSIS
6.2.1.1. THE
UNITED KINGDOM
6.2.1.2. FRANCE
6.2.1.3. GERMANY
6.2.1.4. SPAIN
6.2.1.5. ITALY
6.2.1.6. RUSSIA
6.2.1.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. COUNTRY
ANALYSIS
6.3.1.1. INDIA
6.3.1.2. CHINA
6.3.1.3. JAPAN
6.3.1.4. SOUTH
KOREA
6.3.1.5. ASEAN
COUNTRIES
6.3.1.6. AUSTRALIA
AND NEW ZEALAND
6.3.1.7. REST
OF APAC
6.4. LATIN
AMERICA
6.4.1. COUNTRY
ANALYSIS
6.4.1.1. BRAZIL
6.4.1.2. MEXICO
6.4.1.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA (MEA)
6.5.1. COUNTRY
ANALYSIS
6.5.1.1. SAUDI
ARABIA
6.5.1.2. TURKEY
6.5.1.3. UNITED
ARAB EMIRATES
6.5.1.4. SOUTH
AFRICA
6.5.1.5. REST
OF MIDDLE EAST AND AFRICA
7. COMPANY
PROFILING
7.1. ABBOTT
LABORATORIES INC.
7.2. BIO-RAD
LABORATORIES
7.3. DANAHER
CORPORATION (CEPHEID)
7.4. DAAN
DIAGNOSTICS LTD.
7.5. F.
HOFFMANN-LA ROCHE LTD
7.6. GENENTECH,
INC
7.7. GENOMICTREE,
INC.
7.8. HTG
MOLECULAR DIAGNOSTICS, INC.
7.9. ILLUMINA,
INC
7.10.
INTEGRAGEN S.A
7.11.
LABORATORY CORPORATION OF
AMERICA HOLDINGS
7.12.
LUMINEX CORPORATION
7.13.
MOLECULAR MD, CORP (ACQUIRED
BY ICON)
7.14.
MYRIAD GENETICS, INC.
7.15.
NATERA, INC
7.16.
OXFORD BIODYNAMICS LIMITED
7.17.
PACIFIC BIOSCIENCES OF
CALIFORNIA, INC.
7.18.
PERKINELMER, INC.
7.19.
QIAGEN N.V.
7.20.
ROCHE DIAGNOSTICS CORPORATION
7.21.
THERMO FISHER SCIENTIFIC INC.
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1 GLOBAL GENETIC TESTING MARKET BY REGION 2019-2027 ($ MILLION)
TABLE
2 GLOBAL GENETIC TESTING MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE
3 GLOBAL GENETIC TESTING MARKET BY DISEASE 2019-2027 ($ MILLION)
TABLE
4 GLOBAL GENETIC TESTING MARKET BY
TYPE 2019-2027 ($ MILLION)
TABLE
5 GLOBAL GENETIC TESTING MARKET BY
REGION 2019-2027 ($ MILLION)
TABLE
6 NORTH AMERICA GENETIC TESTING MARKET COUNTRY ANALYSIS 2019-2027($ MILLION)
TABLE
7 EUROPE GENETIC TESTING MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
8 ASIA PACIFIC GENETIC TESTING MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
9 LATIN AMERICA GENETIC TESTING
MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
10 MIDDLE EAST AND AFRICA GENETIC
TESTING MARKET BY COUNTRY 2019-2027 ($ MILLION)
FIGURE
1 GLOBAL GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
2 PORTER’S FIVE FORCE MODEL
FIGURE
3 GLOBAL GENETIC TESTING MARKET BY
CYTOGENETIC TESTING 2019-2027($ MILLION)
FIGURE
4 GLOBAL GENETIC TESTING MARKET BY
BIOCHEMICAL TESTING 2019-2027($ MILLION)
FIGURE
5 GLOBAL GENETIC TESTING MARKET BY
MOLECULAR TESTING 2019-2027($ MILLION)
FIGURE
6 GLOBAL GENETIC TESTING MARKET BY
ALZHEIMER’S DISEASE 2019-2027($ MILLION)
FIGURE
7 GLOBAL GENETIC TESTING MARKET BY
CANCER 2019-2027($ MILLION)
FIGURE
8 GLOBAL GENETIC TESTING MARKET BY
CYSTIC FIBROSIS 2019-2027($ MILLION)
FIGURE
9 GLOBAL GENETIC TESTING MARKET BY
SICKLE CELL ANEMIA 2019-2027($ MILLION)
FIGURE
10 GLOBAL GENETIC TESTING MARKET BY
DUCHENNE MUSCULAR DYSTROPHY 2019-2027($ MILLION)
FIGURE
11 GLOBAL GENETIC TESTING MARKET BY
THALASSEMIA 2019-2027($ MILLION)
FIGURE
12 GLOBAL GENETIC TESTING MARKET BY
HUNTINGTON’S DISEASE 2019-2027($ MILLION)
FIGURE
13 GLOBAL GENETIC TESTING MARKET BY
SPECIAL DISEASES 2019-2027($ MILLION)
FIGURE
14 GLOBAL GENETIC TESTING MARKET BY
OTHER DISEASES 2019-2027($ MILLION)
FIGURE
15 GLOBAL GENETIC TESTING MARKET BY
CARRIER TESTING 2019-2027($ MILLION)
FIGURE
16 GLOBAL GENETIC TESTING MARKET BY
DIAGNOSTIC TESTING 2019-2027($ MILLION)
FIGURE
17 GLOBAL GENETIC TESTING MARKET BY
NEWBORN SCREENING 2019-2027($ MILLION)
FIGURE
18 GLOBAL GENETIC TESTING MARKET BY
PREDICTIVE AND PRESYMPTOMATIC TESTING 2019-2027($ MILLION)
FIGURE
19 GLOBAL GENETIC TESTING MARKET BY
PRENATAL TESTING 2019-2027($ MILLION)
FIGURE
20 GLOBAL GENETIC TESTING MARKET BY
PHARMACOGENOMICS 2019-2027($ MILLION)
FIGURE
21 GLOBAL GENETIC TESTING MARKET BY
OTHER TYPES 2019-2027($ MILLION)
FIGURE
22 GLOBAL GENETIC TESTING MARKET SHARE
BY REGION 2018 & 2027 (%)
FIGURE
23 HEALTHCARE EXPENDITURE IN THE U.S.
2014-2025 (% OF GDP)
FIGURE
24 THE UNITED STATES GENETIC TESTING
MARKET 2019-2027($ MILLION)
FIGURE
25 CANADA GENETIC TESTING MARKET
2019-2027($ MILLION)
FIGURE
26 THE UNITED KINGDOM GENETIC TESTING
MARKET 2019-2027 ($ MILLION)
FIGURE
27 FRANCE GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
28 GERMANY GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
29 SPAIN GENETIC TESTING MARKET 2019-2027
($ MILLION)
FIGURE
30 ITALY GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
31 RUSSIA GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
32 REST OF EUROPE GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
33 INDIA GENETIC TESTING MARKET 2019-2027
($ MILLION)
FIGURE
34 CHINA GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
35 JAPAN GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
36 SOUTH KOREA GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
37 ASEAN COUNTRIES GENETIC TESTING
MARKET 2019-2027 ($ MILLION)
FIGURE
38 AUSTRALIA AND NEW ZEALAND GENETIC
TESTING MARKET 2019-2027 ($ MILLION)
FIGURE
39 REST OF APAC GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
40 BRAZIL GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
41 MEXICO GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
42 REST OF LATIN AMERICA GENETIC TESTING
MARKET 2019-2027 ($ MILLION)
FIGURE
43 SAUDI ARABIA GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
44 TURKEY GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
45 UAE GENETIC TESTING MARKET 2019-2027
($ MILLION)
FIGURE
46 SOUTH AFRICA GENETIC TESTING MARKET
2019-2027 ($ MILLION)
FIGURE
47 REST OF MIDDLE EAST AND AFRICA
GENETIC TESTING MARKET 2019-2027 ($ MILLION)